Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition

Cancer and normal cells use multiple antiapoptotic BCL2 proteins to prevent cell death. Therapeutic targeting of multiple BCL2 family proteins enhances tumor killing but is also associated with increased systemic toxicity. Here, we demonstrate that the dual targeting of MCL1 and BCL2 proteins using...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Bala Tannan, Neeta, Manzari, Mandana T., Herviou, Laurie, Da Silva Ferreira, Mariana, Hagen, Connor, Kiguchi, Hiroto, Manova-Todorova, Katia, Seshan, Venkatraman, de Stanchina, Elisa, Heller, Daniel A., Younes, Anas
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2021
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8057264/
https://ncbi.nlm.nih.gov/pubmed/33067607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020008017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars